Exponent (NASDAQ:EXPO) has had a rough three months with its share price down 15%. However, stock prices are usually driven by a company’s financials over the long term, which in this case look pretty ...

Exponent’s revenue has grown at a CAGR of 6% while EBITDA has at 8%. This has been driven by its fantastic business model and industry tailwinds. Exponent provides highly complex consulting services ...

Did you know there are some financial metrics that can provide clues of a potential multi-bagger? Typically, we'll ...

Owners notice dog keeps sitting in same spot—then uncover touching reason New virus strain spikes in 9 US states with symptoms from brain fog to persistent cough My Dad Was Gay — But Married To My Mom ...

After several tireless days we have finished crunching the numbers from nearly 900 13F filings issued by the elite hedge funds and other investment firms that we track at Insider Monkey, which ...

Prosper Stars & Stripes, a long/short equity fund, recently released its second quarter 2025 investor letter. A copy of the letter can be downloaded here. The fund underperformed and generated a net ...

Exponent's (NASDAQ:EXPO) stock up by 2.8% over the past month. Given its impressive performance, we decided to study the company's key financial indicators as a company's long-term fundamentals ...

Fintel reports that on December 15, 2025, UBS maintained coverage of Exponent (NasdaqGS:EXPO) with a Neutral recommendation. Analyst Price Forecast Suggests 14.98% Upside As of December 6, 2025, the ...

One stock that might be an intriguing choice for investors right now is Exponent Inc.EXPO. This is because this security in the Consulting space is seeing solid earnings estimate revision activity, ...

Exponent soars on impressive Q1 FY24 results, with sales surging 3.3% YoY to $144.933M, outperforming estimates. Engineering and scientific services dominate revenue, comprising 84% of Q1 earnings, ...